Titre : Amérique du Sud

Amérique du Sud : Questions médicales fréquentes

Termes MeSH sélectionnés :

Down-Regulation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Amérique du Sud : Questions médicales les plus fréquentes", "headline": "Amérique du Sud : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Amérique du Sud : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-26", "dateModified": "2025-02-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Amérique du Sud" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Amériques", "url": "https://questionsmedicales.fr/mesh/D000569", "about": { "@type": "MedicalCondition", "name": "Amériques", "code": { "@type": "MedicalCode", "code": "D000569", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Argentine", "alternateName": "Argentina", "url": "https://questionsmedicales.fr/mesh/D001118", "about": { "@type": "MedicalCondition", "name": "Argentine", "code": { "@type": "MedicalCode", "code": "D001118", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.077" } } }, { "@type": "MedicalWebPage", "name": "Bolivie", "alternateName": "Bolivia", "url": "https://questionsmedicales.fr/mesh/D001838", "about": { "@type": "MedicalCondition", "name": "Bolivie", "code": { "@type": "MedicalCode", "code": "D001838", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.136" } } }, { "@type": "MedicalWebPage", "name": "Brésil", "alternateName": "Brazil", "url": "https://questionsmedicales.fr/mesh/D001938", "about": { "@type": "MedicalCondition", "name": "Brésil", "code": { "@type": "MedicalCode", "code": "D001938", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.176" } } }, { "@type": "MedicalWebPage", "name": "Chili", "alternateName": "Chile", "url": "https://questionsmedicales.fr/mesh/D002677", "about": { "@type": "MedicalCondition", "name": "Chili", "code": { "@type": "MedicalCode", "code": "D002677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.235" } } }, { "@type": "MedicalWebPage", "name": "Colombie", "alternateName": "Colombia", "url": "https://questionsmedicales.fr/mesh/D003105", "about": { "@type": "MedicalCondition", "name": "Colombie", "code": { "@type": "MedicalCode", "code": "D003105", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.284" } } }, { "@type": "MedicalWebPage", "name": "Équateur", "alternateName": "Ecuador", "url": "https://questionsmedicales.fr/mesh/D004484", "about": { "@type": "MedicalCondition", "name": "Équateur", "code": { "@type": "MedicalCode", "code": "D004484", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.362" } } }, { "@type": "MedicalWebPage", "name": "Guyane française", "alternateName": "French Guiana", "url": "https://questionsmedicales.fr/mesh/D005616", "about": { "@type": "MedicalCondition", "name": "Guyane française", "code": { "@type": "MedicalCode", "code": "D005616", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.435" } } }, { "@type": "MedicalWebPage", "name": "Guyana", "alternateName": "Guyana", "url": "https://questionsmedicales.fr/mesh/D006172", "about": { "@type": "MedicalCondition", "name": "Guyana", "code": { "@type": "MedicalCode", "code": "D006172", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.488" } } }, { "@type": "MedicalWebPage", "name": "Paraguay", "alternateName": "Paraguay", "url": "https://questionsmedicales.fr/mesh/D010239", "about": { "@type": "MedicalCondition", "name": "Paraguay", "code": { "@type": "MedicalCode", "code": "D010239", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.656" } } }, { "@type": "MedicalWebPage", "name": "Pérou", "alternateName": "Peru", "url": "https://questionsmedicales.fr/mesh/D010568", "about": { "@type": "MedicalCondition", "name": "Pérou", "code": { "@type": "MedicalCode", "code": "D010568", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.702" } } }, { "@type": "MedicalWebPage", "name": "Suriname", "alternateName": "Suriname", "url": "https://questionsmedicales.fr/mesh/D013532", "about": { "@type": "MedicalCondition", "name": "Suriname", "code": { "@type": "MedicalCode", "code": "D013532", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.833" } } }, { "@type": "MedicalWebPage", "name": "Uruguay", "alternateName": "Uruguay", "url": "https://questionsmedicales.fr/mesh/D014583", "about": { "@type": "MedicalCondition", "name": "Uruguay", "code": { "@type": "MedicalCode", "code": "D014583", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.904" } } }, { "@type": "MedicalWebPage", "name": "Venezuela", "alternateName": "Venezuela", "url": "https://questionsmedicales.fr/mesh/D014687", "about": { "@type": "MedicalCondition", "name": "Venezuela", "code": { "@type": "MedicalCode", "code": "D014687", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.757.943" } } } ], "about": { "@type": "MedicalCondition", "name": "Amérique du Sud", "alternateName": "South America", "code": { "@type": "MedicalCode", "code": "D013020", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "M Mabel Ribicich", "url": "https://questionsmedicales.fr/author/M%20Mabel%20Ribicich", "affiliation": { "@type": "Organization", "name": "Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Parasitología y Enfermedades Parasitarias, Av. San Martín 5285 (1417DSM), Buenos Aires, Argentina; CONICET - Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Instituto de Investigaciones en Producción Animal (INPA), Buenos Aires, Argentina. Electronic address: mribicich@fvet.uba.ar." } }, { "@type": "Person", "name": "Fernando A Fariña", "url": "https://questionsmedicales.fr/author/Fernando%20A%20Fari%C3%B1a", "affiliation": { "@type": "Organization", "name": "Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Parasitología y Enfermedades Parasitarias, Av. San Martín 5285 (1417DSM), Buenos Aires, Argentina; CONICET - Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Instituto de Investigaciones en Producción Animal (INPA), Buenos Aires, Argentina." } }, { "@type": "Person", "name": "Tatiana Aronowicz", "url": "https://questionsmedicales.fr/author/Tatiana%20Aronowicz", "affiliation": { "@type": "Organization", "name": "Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Parasitología y Enfermedades Parasitarias, Av. San Martín 5285 (1417DSM), Buenos Aires, Argentina; Servicio Nacional de Sanidad Animal, SENASA, Argentina." } }, { "@type": "Person", "name": "Mariano E Ercole", "url": "https://questionsmedicales.fr/author/Mariano%20E%20Ercole", "affiliation": { "@type": "Organization", "name": "Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Parasitología y Enfermedades Parasitarias, Av. San Martín 5285 (1417DSM), Buenos Aires, Argentina; CONICET - Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Instituto de Investigaciones en Producción Animal (INPA), Buenos Aires, Argentina." } }, { "@type": "Person", "name": "Clara Bessi", "url": "https://questionsmedicales.fr/author/Clara%20Bessi", "affiliation": { "@type": "Organization", "name": "Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Cátedra de Parasitología y Enfermedades Parasitarias, Av. San Martín 5285 (1417DSM), Buenos Aires, Argentina; CONICET - Universidad de Buenos Aires, Facultad de Ciencias Veterinarias, Instituto de Investigaciones en Producción Animal (INPA), Buenos Aires, Argentina." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Different pathways for exogenous ABA-mediated down-regulation of cadmium accumulation in plants under different iron supplies.", "datePublished": "2022-08-13", "url": "https://questionsmedicales.fr/article/36027744", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jhazmat.2022.129769" } }, { "@type": "ScholarlyArticle", "name": "Down regulation of the inverse relationship between parathyroid hormone and irisin in male vitamin D-sufficient HIV patients.", "datePublished": "2023-05-28", "url": "https://questionsmedicales.fr/article/37245160", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40618-023-02112-5" } }, { "@type": "ScholarlyArticle", "name": "Down-regulation of circPTTG1IP induces hepatocellular carcinoma development via miR-16-5p/RNF125/JAK1 axis.", "datePublished": "2022-06-13", "url": "https://questionsmedicales.fr/article/35710093", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.canlet.2022.215778" } }, { "@type": "ScholarlyArticle", "name": "C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process.", "datePublished": "2022-09-25", "url": "https://questionsmedicales.fr/article/36263169", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7150/ijbs.73192" } }, { "@type": "ScholarlyArticle", "name": "ROR2 deficit may induce the tetralogy of Fallot via down-regulating of β-catenin/SOX3/HSPA6 in vitro and in vivo.", "datePublished": "2023-09-25", "url": "https://questionsmedicales.fr/article/37749917", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jcmm.17969" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Amériques", "item": "https://questionsmedicales.fr/mesh/D000569" }, { "@type": "ListItem", "position": 4, "name": "Amérique du Sud", "item": "https://questionsmedicales.fr/mesh/D013020" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Amérique du Sud - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Amérique du Sud", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Amérique du Sud", "description": "Comment diagnostiquer le paludisme en Amérique du Sud ?\nQuels tests pour la dengue ?\nComment identifier la fièvre jaune ?\nQuels examens pour la leptospirose ?\nComment diagnostiquer la maladie de Chagas ?", "url": "https://questionsmedicales.fr/mesh/D013020?mesh_terms=Down-Regulation&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Amérique du Sud", "description": "Quels sont les symptômes du paludisme ?\nQuels signes de la dengue ?\nQuels symptômes de la fièvre jaune ?\nQuels symptômes de la leptospirose ?\nQuels signes de la maladie de Chagas ?", "url": "https://questionsmedicales.fr/mesh/D013020?mesh_terms=Down-Regulation&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Amérique du Sud", "description": "Comment prévenir le paludisme ?\nQuelles mesures pour éviter la dengue ?\nComment se protéger contre la fièvre jaune ?\nQuelles précautions pour la leptospirose ?\nComment prévenir la maladie de Chagas ?", "url": "https://questionsmedicales.fr/mesh/D013020?mesh_terms=Down-Regulation&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Amérique du Sud", "description": "Quel traitement pour le paludisme ?\nComment traiter la dengue ?\nQuel traitement pour la fièvre jaune ?\nComment traiter la leptospirose ?\nQuel traitement pour la maladie de Chagas ?", "url": "https://questionsmedicales.fr/mesh/D013020?mesh_terms=Down-Regulation&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Amérique du Sud", "description": "Quelles complications du paludisme ?\nQuelles complications de la dengue ?\nQuelles complications de la fièvre jaune ?\nQuelles complications de la leptospirose ?\nQuelles complications de la maladie de Chagas ?", "url": "https://questionsmedicales.fr/mesh/D013020?mesh_terms=Down-Regulation&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Amérique du Sud", "description": "Quels sont les facteurs de risque du paludisme ?\nQuels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour la fièvre jaune ?\nQuels facteurs de risque pour la leptospirose ?\nQuels facteurs de risque pour la maladie de Chagas ?", "url": "https://questionsmedicales.fr/mesh/D013020?mesh_terms=Down-Regulation&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le paludisme en Amérique du Sud ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins pour détecter le parasite Plasmodium." } }, { "@type": "Question", "name": "Quels tests pour la dengue ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques et PCR sont utilisés pour confirmer une infection par le virus de la dengue." } }, { "@type": "Question", "name": "Comment identifier la fièvre jaune ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic est établi par des tests sérologiques et l'historique de vaccination." } }, { "@type": "Question", "name": "Quels examens pour la leptospirose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques et PCR sont utilisés pour diagnostiquer la leptospirose." } }, { "@type": "Question", "name": "Comment diagnostiquer la maladie de Chagas ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des tests sérologiques et parfois par biopsie de tissu." } }, { "@type": "Question", "name": "Quels sont les symptômes du paludisme ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont fréquents." } }, { "@type": "Question", "name": "Quels signes de la dengue ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, douleurs articulaires, éruptions cutanées et saignements peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes de la fièvre jaune ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs abdominales, jaunisse et saignements sont des signes typiques." } }, { "@type": "Question", "name": "Quels symptômes de la leptospirose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, maux de tête, douleurs musculaires et éruptions cutanées peuvent apparaître." } }, { "@type": "Question", "name": "Quels signes de la maladie de Chagas ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, fièvre, gonflement des paupières et douleurs abdominales peuvent se manifester." } }, { "@type": "Question", "name": "Comment prévenir le paludisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires, des répulsifs et prendre des médicaments préventifs." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la dengue ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques." } }, { "@type": "Question", "name": "Comment se protéger contre la fièvre jaune ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination est la meilleure méthode de prévention contre la fièvre jaune." } }, { "@type": "Question", "name": "Quelles précautions pour la leptospirose ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les contacts avec des eaux contaminées et porter des vêtements de protection." } }, { "@type": "Question", "name": "Comment prévenir la maladie de Chagas ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les piqûres de triatomes et améliorer les conditions de logement." } }, { "@type": "Question", "name": "Quel traitement pour le paludisme ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antipaludiques comme la chloroquine et l'artémisinine sont couramment utilisés." } }, { "@type": "Question", "name": "Comment traiter la dengue ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour la fièvre jaune ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de traitement antiviral ; la prévention par vaccination est cruciale." } }, { "@type": "Question", "name": "Comment traiter la leptospirose ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques comme la doxycycline sont utilisés pour traiter la leptospirose." } }, { "@type": "Question", "name": "Quel traitement pour la maladie de Chagas ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments comme le benznidazole sont utilisés pour traiter l'infection." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Anémie sévère, défaillance organique et coma peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La dengue sévère peut entraîner des hémorragies et un choc hypovolémique." } }, { "@type": "Question", "name": "Quelles complications de la fièvre jaune ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Insuffisance hépatique et hémorragies peuvent survenir dans les cas graves." } }, { "@type": "Question", "name": "Quelles complications de la leptospirose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Insuffisance rénale, méningite et hémorragies peuvent être des complications graves." } }, { "@type": "Question", "name": "Quelles complications de la maladie de Chagas ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles cardiaques et des problèmes digestifs chroniques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du paludisme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones endémiques et ne pas utiliser de protection contre les moustiques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dengue ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les zones urbaines avec des eaux stagnantes et un climat chaud favorisent la dengue." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la fièvre jaune ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des zones endémiques sans vaccination augmente le risque d'infection." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la leptospirose ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Travailler dans l'agriculture ou être exposé à des eaux contaminées augmente le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la maladie de Chagas ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des habitations en terre et être exposé aux triatomes augmente le risque." } } ] } ] }

Sources (10000 au total)

Down regulation of the inverse relationship between parathyroid hormone and irisin in male vitamin D-sufficient HIV patients.

Infection with the human immunodeficiency virus (HIV) predisposes to endocrine disorders, manifesting as a metabolic phenotype that affects the entire adipose-musculoskeletal unit (AMS). The present c... 46 HIV-infected individuals and 39 healthy controls (all men) were included in the study. Anthropometric data, adipokine levels, 25-hydroxyvitamin D [(25(OH)D)] and parathyroid hormone (PTH) concentra... Mean adiponectin concentrations were significantly lower in the HIV group compared to the control group: 5868 ± 3668 vs 9068 ± 4277 ng/mL, p = 0.011. The same was applicable to irisin concentrations: ... Our results are the first to suggest a possible down regulation of the inverse relationship between PTH and irisin in HIV patients and to highlight that AMS dyshomeostasis could be involved in the dev...

C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process.

Previous data indicate that C3G (RapGEF1) main isoform is highly expressed in liver progenitor cells (or oval cells) compared to adult mature hepatocytes, suggesting it may play an important role in o...

Paiteling induces apoptosis of cervical cancer cells by down-regulation of the E6/E7-Pi3k/Akt pathway: A network pharmacology.

Human papillomavirus (HPV) infection is considered to be the main pathogen causing intraepithelial neoplasia. Paiteling (PTL) has been used to treat intraepithelial neoplasia caused by human papilloma... This study designed a comprehensive strategy to study the pharmacological mechanism of paiteling in regulating cervical cancer cell apoptosis by integrating LC-MS/MS, network pharmacology and pharmaco... We used liquid chromatography-tandem mass spectrometry to detect the active substances in PTL and performed protein-protein interaction analysis on the intersection of the targets of these key compoun... The protein-protein interaction network predicted that AKT1, TP53, MYC, STAT3, MTOR, and MAPK were pivotal targets for PTL to inhibit epithelial neoplasia. KEGG enrichment analysis showed that the Pi3... PTL can induce cervical cancer cell apoptosis by inhibiting the E6/E7-Pi3k/Akt signaling pathway. It may provide an effective alternative strategy of traditional Chinese medicine for the treatment of ...

Down-regulation of hsa-circ-0107593 promotes osteogenic differentiation of hADSCs via miR-20a-5p/SMAD6 signaling.

Increasing evidence indicated circRNAs were involved in stem cells osteogenesis differentiation. Herein, we aimed to clarify the role of hsa-circ-0107593 during the osteogenesis process of human adipo... The ring structure of hsa-circ-0107593 was confirmed using RNase R treatment and Sanger sequencing. Nucleoplasmic separation and fluorescence in situ hybridization detected hsa-circ-0107593 distributi... RT-PCR results exhibited that hsa-circ-0107593 was downregulated while miR-20a-5p was upregulated during hADSCs osteogenesis. In vivo and in vitro experiments results indicated that knocking down hsa-... Knocking down hsa-circ-0107593 acts as a positive factor of the osteogenic differentiation of hADSCs via miR-20a-5p/SMAD6 signaling....

Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD.

Killer cell lectin-like receptor B1 (KLRB1) is implicated in cancer progression and immunity. In this study, we aimed to evaluate the expression levels of KLRB1 in lung adenocarcinoma (LUAD) and analy...

Qi Jing Mingmu decoction inhibits the p38 signaling pathway in conjunctivochalasis fibroblasts by down-regulation of Th17 cell differentiation.

Qi Jing Mingmu (QJMM) decoction is a traditional Chinese medicine that has been widely used for the clinical treatment of conjunctivochalasis (CCH). It is an effective treatment to relieve ocular symp... To determine whether QJMM decoction affected T helper 17 (Th17) cell differentiation of CCH patients.... Blood samples and conjunctival tissues were collected from CCH patients and normal controls. The fibroblasts were separately induced, and CD4... Compared with normal controls, Th17 cell numbers and serum levels of IL-17 and IL-22 were elevated in patients with CCH. QJMM decoction down-regulated the expressions of IL-17, IL-22, and STAT3 of CD4... QJMM decoction inhibited Th17 cell differentiation of CD4...